February 2013 FDA Recall Drug by Hospira Inc.
D-243-2013 - Lack of Assurance of Sterility

This Class II drug recall was voluntarily initiated by Hospira Inc. on February 18, 2013 for the product Drug. The FDA reported the reason for recall as lack of assurance of sterility. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-243-2013

Reason for Recall
Lack of Assurance of Sterility: The product is being recall due to the product lot being incorrectly released without meeting product specifications. There is the potential for the solution to leak from the administrative port to the fill tube seal.
Initiated
02-18-2013
Reported
04-10-2013
Quantity
624,240 units

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
0.9% Sodium Chloride Injection, USP, 50 mL, Manufactured by Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7984-36 Hospira, Inc., Lake Forest, IL 60045

Batch or Lot Expiration Information

Lot# : 22-028-JT Exp 04/14